During the last session, Humacyte Inc (NASDAQ:HUMA)’s traded shares were 2.64 million, with the beta value of the company hitting 1.37. At the end of the trading day, the stock’s price was $2.96, reflecting an intraday loss of -6.03% or -$0.19. The 52-week high for the HUMA share is $9.97, that puts it down -236.82 from that peak though still a striking 5.07% gain since the share price plummeted to a 52-week low of $2.81. The company’s market capitalization is $380.86M, and the average trade volume was 4.19 million shares over the past three months.
Humacyte Inc (HUMA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.29. HUMA has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.25.
Humacyte Inc (NASDAQ:HUMA) trade information
Humacyte Inc (HUMA) registered a -6.03% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.03% in intraday trading to $2.96, hitting a weekly high. The stock’s 5-day price performance is -12.17%, and it has moved by -32.27% in 30 days. Based on these gigs, the overall price performance for the year is -16.15%.
The consensus price target of analysts on Wall Street is $8, which implies an increase of 63.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $10 respectively. As a result, HUMA is trading at a discount of -237.84% off the target high and -102.7% off the low.
Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 800.25k by the end of current fiscal year.
While earnings are projected to return -26.64% in 2025, the next five years will return 41.70% per annum.
HUMA Dividends
Humacyte Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.73 million shares, is of VANGUARD GROUP INC’s that is approximately 4.3693% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $22.7 million.
